Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.HELIYON.2024.E33143 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The HLA-B*35 alleles have been associated with a slow or rapid progression of HIV-1 infection. However, the mechanisms related to HIV-1 progression have yet to be entirely understood. Several reports indicate that the binding affinity between the HLA-I molecule and peptides could be associated with an increased CD8+ T-cell response. Novel HLA-B*35-restricted mutated variants have been described from HSNQVSQNY (HY9) and HPVHAGPIA (HA9) epitopes. Bioinformatic analysis has indicated that these mutated epitopes show low and high binding affinity towards HLA-B*35, respectively. However, the polyfunctionality of CD8+ T-cells stimulated with these mutated and wild-type epitopes has yet to be reported. The results suggest that the lowbinding affinity H124 N/S125 N/N126S mutated peptide in the HY9 epitope induced a lower percentage of CD107a+CD8+ T-cells than the wild-type epitope. Instead, the high-binding affinity peptides I223V and I223A in the HA9 epitope induced a significantly higher frequency of polyfunctional CD8+ T-cells. Also, a higher proportion of CD8+ T-cells with two functions, with Granzyme B+ Perforin+ being the predominant profile, was observed after stimulation with mutated peptides associated with high binding affinity in the HA9 epitope. These results suggest that the high-affinity mutated peptides induced a more polyfunctional CD8+ T-cell response, which could be related to the control of viral replication.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | S, Alexandra | - | |
| 1 | Sánchez-Martínez, Alexandra | - |
Universidad de Antioquia - Colombia
|
| 2 | Hoyos, Sofia Giraldo | - |
Corp Invest Biol - Colombia
Corporacion para Investigaciones Biologicas - Colombia |
| 2 | Giraldo Hoyos, Sofía | - |
Corporacion para Investigaciones Biologicas - Colombia
|
| 3 | Alzate-Angel, Juan Carlos | - |
UNIV ANTIOQUIA - Colombia
Univ Santander CIB UDES - Colombia Universidad de Antioquia - Colombia Universidad de Santander - Colombia |
| 4 | Guzam, Fanny | - |
Pontificia Universidad Católica de Valparaíso - Chile
|
| 4 | Guzmán, Fanny | - |
Pontificia Universidad Católica de Valparaíso - Chile
|
| 5 | Roman, Tanya | - |
Pontificia Universidad Católica de Valparaíso - Chile
|
| 6 | Velilla, Paula A. | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 7 | Acevedo-Saenz, Liliana | - |
Univ CES - Colombia
Universidad CES - Colombia |
| Fuente |
|---|
| Universidad de Antioquia |
| Universidad de Antioquia-UdeA |
| MinCiencias |
| Ministerio de Ciencia, Tecnología e Innovación |
| HIV healthcare program of “Corporación para Investigaciones Biológicas |
| Agradecimiento |
|---|
| This study was financed by Universidad de Antioquia-UdeA and MINCIENCIAS (111,577,757,038; contract: 773-2017) . |
| The authors thank the patients and the HIV healthcare program of \u201CCorporaci\u00F3n para Investigaciones Biol\u00F3gicas \u2013 CIB\u201D for their help in patient recruitment and technical assistance. |
| The authors thank the patients and the HIV healthcare program of \u201CCorporaci\u00F3n para Investigaciones Biol\u00F3gicas \u2013 CIB\u201D for their help in patient recruitment and technical assistance. |